Australia, June 7 -- Amgen Inc., owns the trademark (2493984) for 'MARITIDE' till Oct. 28, 2034.
Status: registered:
Registered/protected
Class: 42 [Research and development of pharmaceutical preparations; research and development of pharmaceutical preparations in the field of metabolic diseases, namely weight management and diabetes; medical and scientific research information in clinical trials in the field of metabolic diseases, namely weight management and diabetes; provision of medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of metabolic diseases, namely weight management and diabetes via a website; provision of medical and scientific research information about pharmaceuticals preparations in the field of metabolic diseases, namely weight management and diabetes via a website; provision of non-downloadable computer software that enables users to access, manage, update and display electronic databases in the field of metabolic diseases, namely weight management and diabetes via a website.]
Type of Mark: Word
Date of Acceptance: Dec. 20, 2024
Registration Advertised: June 6
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2493984.
Disclaimer: Curated by HT Syndication.
